170 related articles for article (PubMed ID: 16281837)
1. [An evidence-based approach to writing reviews as illustrated by treatment of erectile dysfunction].
Apolikhin OP; Abdullin II
Urologiia; 2005; (5):31-5. PubMed ID: 16281837
[TBL] [Abstract][Full Text] [Related]
2. Erectile dysfunction.
Tharyan P; Gopalakrishanan G
Clin Evid; 2006 Jun; (15):1227-51. PubMed ID: 16973050
[No Abstract] [Full Text] [Related]
3. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
Ali ST
Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
[TBL] [Abstract][Full Text] [Related]
4. The application of quantitative methods for identifying and exploring the presence of bias in systematic reviews: PDE-5 inhibitors for erectile dysfunction.
Bekkering GE; Abou-Setta AM; Kleijnen J
Int J Impot Res; 2008; 20(3):264-77. PubMed ID: 18059501
[TBL] [Abstract][Full Text] [Related]
5. Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?
Doggrell S
Int J Impot Res; 2007; 19(3):281-95. PubMed ID: 17183346
[TBL] [Abstract][Full Text] [Related]
6. Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: results from the Canadian 'Treatment of Erectile Dysfunction' observational study.
Lee J; Pommerville P; Brock G; Gagnon R; Mehta P; Krisdaphongs M; Chan M; Chan J; Dickson R
BJU Int; 2006 Sep; 98(3):623-9. PubMed ID: 16925764
[TBL] [Abstract][Full Text] [Related]
7. [Place of intra-urethral prostaglandin E1 for the treatment of erectile dysfunction].
Amar E
Contracept Fertil Sex; 1999; 27(7-8):548-52. PubMed ID: 10495573
[TBL] [Abstract][Full Text] [Related]
8. Erectile dysfunction.
O'Leary M;
Clin Evid; 2002 Dec; (8):872-80. PubMed ID: 15259177
[No Abstract] [Full Text] [Related]
9. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
[TBL] [Abstract][Full Text] [Related]
10. The treatment of erectile dysfunction study: focus on treatment satisfaction of patients and partners.
Brock G; Chan J; Carrier S; Chan M; Salgado L; Klein AH; Lang C; Horner R; Gutkin S; Dickson R
BJU Int; 2007 Feb; 99(2):376-82. PubMed ID: 17155989
[TBL] [Abstract][Full Text] [Related]
11. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
[TBL] [Abstract][Full Text] [Related]
12. Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil.
Ahn TY; Lee SW; Kim SW; Yang DY; Park NC; Min KS; Park K; Paick JS; Dyachkova Y; Dwight T; Lee MS
Asian J Androl; 2007 Nov; 9(6):760-70. PubMed ID: 17968461
[TBL] [Abstract][Full Text] [Related]
13. Erectile dysfunction.
Webber R
Clin Evid; 2004 Jun; (11):1148-57. PubMed ID: 15652056
[No Abstract] [Full Text] [Related]
14. Erectile dysfunction.
Webber R
Clin Evid; 2003 Dec; (10):1003-11. PubMed ID: 15555134
[No Abstract] [Full Text] [Related]
15. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS).
Martin-Morales A; Haro JM; Beardsworth A; Bertsch J; Kontodimas S;
Eur Urol; 2007 Feb; 51(2):541-50; discussion 550. PubMed ID: 17084518
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of erectile dysfunction].
Romics I
Orv Hetil; 2004 Feb; 145(9):491-3. PubMed ID: 15077482
[No Abstract] [Full Text] [Related]
17. [Therapy of erectile dysfunction. Sildenafil remains the gold standard].
MMW Fortschr Med; 2001 Dec; 143(49-50):50-1. PubMed ID: 11808451
[No Abstract] [Full Text] [Related]
18. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
Blonde L
Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
[TBL] [Abstract][Full Text] [Related]
19. Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction.
Shabsigh R; Seftel AD; Rosen RC; Porst H; Ahuja S; Deeley MC; Garcia CS; Giuliano F
Urology; 2006 Oct; 68(4):689-96. PubMed ID: 17070333
[No Abstract] [Full Text] [Related]
20. Erectile dysfunction.
O'Leary M
Clin Evid; 2002 Jun; (7):796-803. PubMed ID: 12230705
[No Abstract] [Full Text] [Related]
[Next] [New Search]
